Allelic variation of killer cell immunoglobulin-like receptor 2DS5 impacts glycosylation altering cell surface expression levels

Human Immunology

Volumn 75, Issue 2, 2014, Pages 124-128

  Steiner, Noriko K ^a   Dakshanamurthy, Sivanesan ^a   Nguyen, Nicholas ^a   Hurley, Carolyn Katovich ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cell surface molecules; Human; Killer cell immunoglobulin like receptors; Natural killer cells; Polymorphism

Indexed keywords

GLYCOSYLATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS 1; RNA ISOFORM; UNCLASSIFIED DRUG; CYTOKINE; ISOPROTEIN; KIR2DS5 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE CONSTRUCT; GENE FREQUENCY; GLYCOSYLATION; IMMUNOPRECIPITATION; MOLECULAR MODEL; MOLECULAR WEIGHT; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; SURFACE PROPERTY; WESTERN BLOTTING; ALLELE; BIOLOGY; CHEMICAL STRUCTURE; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MUTATION; NATURAL KILLER CELL; TRANSGENE;

ALLELES; COMPUTATIONAL BIOLOGY; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RECEPTORS, KIR; TRANSGENES;

EID: 84892371719     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.11.012     Document Type: Article

References (23)

1. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
2. Parham P., Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 2013, 13:133-144.
3. Stewart C.A., Laugier-Anfossi F., Vely F., Saulquin X., Riedmuller J., Tisserant A., et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 2005, 102:13224-13229.
4. *11 while diminishing avidity for HLA-C. J Exp Med 2009, 206:2557-2572.
5. VandenBussche C.J., Mulrooney T.J., Frazier W.R., Dakshanamurthy S., Hurley C.K. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes and Immun 2009, 10:162-173.
6. Vivian J.P., Duncan R.C., Berry R., O'Connor G.M., Reid H.H., Beddoe T., et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011, 479:401-405.
7. Saulquin X., Gastinel L.N., Vivier E. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J Exp Med 2003, 197:933-938.
8. Chiesa M.D., Romeo E., Falco M., Balsamo M., Augugliaro R., Moretta L., et al. Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 2008, 38:2284-2289.
9. Pyo C.W., Wang R., Vu Q., Cereb N., Yang S.Y., Duh F.M., et al. Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics 2013, 14:89.
10. Jiang W., Johnson C., Jayaraman J., Simecek N., Noble J., Moffatt M.F., et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012, 22:1845-1854.
11. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997, 7:753-763.
12. Maxwell L.D., Wallace A., Middleton D., Curran M.D. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002, 60:254-258.
13. Ordonez D., Meenagh A., Gomez-Lozano N., Castano J., Middleton D., Vilches C. Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes. Genes Immun 2008, 9:431-437.
14. Li H., Pascal V., Martin M.P., Carrington M., Anderson S.K. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008, 4:e1000254.
15. Andersson S., Fauriat C., Malmberg J.A., Ljunggren H.G., Malmberg K.J. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009, 114:95-104.
16. Jonsson A.H., Yokoyama W.M. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009, 101:27-79.
17. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006, 203:633-645.
18. Frazier W.R., Steiner N., Hou L., Dakshanamurthy S., Hurley C.K. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunol 2013, 190:6198-6208.
19. Hou L., Chen M., Jiang B., Kariyawasam K., Ng J., Hurley C.K. In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans. Hum Immunol 2009, 70:733-737.
20. Hou L., Steiner N.K., Chen M., Belle I., Kubit A.L., Ng J., et al. Limited allelic diversity of stimulatory two domain killer immunoglobulin-like receptors. Hum Immunol 2008, 69:174-178.
21. Steiner N.K., Dakshanamurthy S., VandenBussche C.J., Hurley C.K. Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics 2008, 60:655-667.
22. Pearlman D.A., Case D.A., Caldwell J.W., Ross W.S., Cheatham T.E., DeBolt S., et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 1995, 91:1-41.
23. Fauriat C., Long E.O., Ljunggren H.G., Bryceson Y.T. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-2176.